Participating Institutes:

The following institutes of the KIT contribute to the BIFTM research, reflecting the interdisciplinarity of this research programme:

Institute of Biological and Chemical Systems (IBCS)

       -  Biological Information Processing (IBCS-BIP)

       -  Functional Molecular Systems (IBCS-FMS)

Institute of Functional Interfaces (IFG)

Institute for Biological Interfaces (IBG)

       -  Biomolecular Micro- and Nanostructures (IBG-1)

       -  Molecular Biophysics (IBG-2)

       -  Macromolecular Materials (IBG-3)

       -  Magnetic Resonance (IBG-4)

       -  Biotechnology and Microbial Genetics (IBG-5)

Institute of Microstructure Technology (IMT)

Institute for Automation and Applied Informatics (IAI)

       -  Automated Image and Data Analysis 

Institute for Technical Chemistry (ITC)

       -  Department of Aerosols and Particles 

Institute for Applied Materials (IAM)

       -  Energy Storage Systems (IAM-ESS)

Zoological Institute (ZOO)

       -  Cell and Neurobiology

       -  Cellular and Developmental Biology

Institute for Organic Chemistry (IOC)

Institute of Applied Physics (APH)

Institute for Applied Biosciences (IAB), Applied Biology

Institute of Process Engineering in Life Sciences (BLT)

       -  Section II: Technical Biology (BLT-TeBi)

       -  Section IV: Biomolecular Separation Engineering (BLT-MAB)

Institute of Nanotechnology (INT)

Institute for Photon Science and Synchrotron Radiation (IPS)

Laboratory for Electron Microscopy (LEM)

                                                                                                   

In the HGF research programme "BioInterfaces in Technology and Medicine", the Institute of Biomaterial Science at Helmholtz-Zentrum Geesthacht (HZG) contributes complementary expertise in polymer chemistry and biological evaluation. Furthermore, their strategic alliance with the Berlin-Brandenburg Center for Regenerative Therapies (BCRT, jointly operated clinical translation centre of Charité Universitätsmedizin Berlin and HZG/Teltow) complements our existing cooperation with clinical scientists.